The comparative effect of Plantago Psyllium, Ocimum Basilicum seeds on non alcoholic fatty liver disease

Comparative study on the effect of Plantago Psyllium and Ocimum Basilicum seeds on body composition, blood sugar, lipid profile, liver enzymes, inflammatory index and sonografic finding in nonalcoholic fatty liver patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014101811763N17

Enrollment

120

Registered

2016-02-04

Start date

2014-08-11

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic Fatty Liver Disease. Fatty (change of) liver, not elsewhere classified

Interventions

Intervention 1: 10 grams of Plantago Psyllium, 5 grams before lunch and 5 grams before dinner with one glass of water during 3 month. Intervention 2: 10 grams of Ocimum Basilicum, 5 grams before lunch

Treatment - Other

10 grams of Plantago Psyllium, 5 grams before lunch and 5 grams before dinner with one glass of water during 3 month.

10 grams of Ocimum Basilicum, 5 grams before lunch and 5 grams before dinner with one glass of water during 3 month.

10 grams mixed of Ocimum Basilicum and Plantago Psyllium, 5 grams before lunch and 5 grams before dinner with one glass of water during 3 month.

The control group.

Eligibility

Sex/Gender

All

Age

20 Years to No maximum

Inclusion criteria

Inclusion criteria: inclusion criteria: Males and females above 20 years nonalcoholic fatty liver that was confirmed at the first time by one specialist. exclusion criteria: Hemocromatosis; insulin injection; persistent use of Corticosteroids; alcohol abuse? pregnancy; lactation? Chronic inflammatory diseases; major operation in 6 months ago; fiber supplements

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
ALT,AST. Timepoint: first and the end of third month. Method of measurement: blood test.;Ultrasound finding. Timepoint: first and the end of third month. Method of measurement: ultrasound.	—

Secondary

Measure	Time frame
Body compositon. Timepoint: first and the end of third month. Method of measurement: body composition analyser.;FBS, LDL, HDL, TG, TC. Timepoint: first and the end of third month. Method of measurement: blood test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGholam Reza Askari

Isfahan University of Medical Sciences

askari@mui.ac.ir+98 31 3792 6000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 27, 2026